- Home
- CLPR vs CRVO Comparison
CLPR vs CRVO Comparison
Compare CLPR & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPR
- CRVO
- Stock Information
- Founded
- CLPR 2015
- CRVO 2001
- Country
- CLPR United States
- CRVO United States
- Employees
- CLPR N/A
- CRVO N/A
- Industry
- CLPR Real Estate Investment Trusts
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CLPR Real Estate
- CRVO Health Care
- Exchange
- CLPR Nasdaq
- CRVO Nasdaq
- Market Cap
- CLPR 57.8M
- CRVO 67.4M
- IPO Year
- CLPR 2017
- CRVO N/A
- Fundamental
- Price
- CLPR $3.61
- CRVO $8.04
- Analyst Decision
- CLPR
- CRVO Strong Buy
- Analyst Count
- CLPR 0
- CRVO 6
- Target Price
- CLPR N/A
- CRVO $17.40
- AVG Volume (30 Days)
- CLPR 80.4K
- CRVO 786.6K
- Earning Date
- CLPR 08-07-2025
- CRVO 08-12-2025
- Dividend Yield
- CLPR 10.73%
- CRVO N/A
- EPS Growth
- CLPR N/A
- CRVO N/A
- EPS
- CLPR N/A
- CRVO N/A
- Revenue
- CLPR $152,413,000.00
- CRVO $9,308,215.00
- Revenue This Year
- CLPR N/A
- CRVO N/A
- Revenue Next Year
- CLPR N/A
- CRVO N/A
- P/E Ratio
- CLPR N/A
- CRVO N/A
- Revenue Growth
- CLPR 8.63
- CRVO 15.14
- 52 Week Low
- CLPR $3.44
- CRVO $1.80
- 52 Week High
- CLPR $7.12
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- CLPR 42.03
- CRVO 54.02
- Support Level
- CLPR $3.72
- CRVO $7.81
- Resistance Level
- CLPR $4.39
- CRVO $13.13
- Average True Range (ATR)
- CLPR 0.19
- CRVO 1.03
- MACD
- CLPR -0.03
- CRVO 0.10
- Stochastic Oscillator
- CLPR 11.12
- CRVO 16.88
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.